MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

MDS Virtual Congress 2021

September 17-22, 2021. Virtual Congress. www.mdscongress.org

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • The pandemic stress impact on disease progression in COVID-19 seronegative patients with idiopathic Parkinson’s Disease.

    M. Hansen, T. Marques, C. Pauly, L. Delacour, C. Martin-Gallausiaux, P. Wilmes, R. Krüger, N J. Diederich (Strassen, Luxembourg)

  • The PD-1102 trial in advanced Parkinson’s disease: safety and clinical outcomes from a 3-year phase 1b study of AADC gene therapy administered via a posterior approach

    S. Factor, R. Gross, A. van Laar, C. Christine, P. Larson, S. Kostyk, R. Lonser, E. Fine, O. Kwhaja, C. Li, A. Meier, G. Liang, E. Roberts, R. Richardson (Atlanta, USA)

  • The potential impact of physical activity to increase serum a-klotho levels in people with Parkinson’s disease

    M. Al-Wardat (Aqaba, Jordan)

  • The potential of GBA1 knock-out medaka as a model animal in the search for therapeutic compounds for GBA1-related α-synucleinopathy

    E. Nakanishi, M. Sawamura, Y. Taruno, N. Uemura, H. Yamakado, R. Takahashi (Kyoto, Japan)

  • The prevalence and types of postural deformities in Thai patients with Parkinson’s disease: A single-center study

    M. Vichutavate, P. Srivanitchapoom (Bangkok, Thailand)

  • The prevalence of sarcopenia in Parkinson’s disease and related disorders

    A. Hart, F. Barker, A. Sayer, A. Granic, A. Yarnall (Newcastle Upon Tyne, United Kingdom)

  • The PRIME Qual study protocol: A qualitative exploration of the experiences of patients, caregivers/families and hospital/intervention staff of the PRIME Randomised Controlled Trial

    H. Brant, E. Henderson, D. Gervaise-Brazier, F. Lithander, E. Tenison, S. Redwood (Bristol, United Kingdom)

  • The Prodromal PD study – multiple biomarkers for early diagnosis?

    P. de Roos, D. Nyholm, M. Ingelsson (Uppsala, Sweden)

  • The Relationship Between Leptin Levels and Cognitive Status and Disease Stages in Patients with Alzheimer’s Disease

    İ. Tuncer, G. Yuksel, H. Ti̇reli̇ (Kars, Turkey)

  • The responsiveness of arm swing to dopaminergic medication in Parkinson’s disease depends on task complexity

    E. Warmerdam, R. Romijnders, C. Hansen, M. Elshehabi, M. Zimmermann, F. Metzger, A. von Thaler, D. Berg, G. Schmidt, W. Maetzler (Kiel, Germany)

  • « Previous Page
  • 1
  • …
  • 120
  • 121
  • 122
  • 123
  • 124
  • …
  • 132
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley